Whole-exome sequencing identifies novel mutation in intrahepatic cholestasis of pregnancy: A case report and literature review

Abstract

Objective

Intrahepatic cholestasis of pregnancy (ICP) is a pregnancy-specific liver disease characterized by pruritus and elevated total bile acid (TBA) levels. The most serious impact of ICP is sudden unexplained intrauterine fetal death, especially when an associated TBA ≥ 100 µmol/L is confirmed.

Methods

We report a case of a 27-year-old female patient with early-onset severe refractory ICP. Whole-exome sequencing and mutation analyses were performed to obtain genetic data on the patient and her mother. Sanger sequencing was performed to screen the mutation site. Computer-based algorithms were applied to predict the pathogenesis of the identified mutation. Subsequently, we conducted a literature review to characterize the pathological features and perinatal management of severe refractory ICP, especially ICP with genetic susceptibility.

Results

A heterozygous mutation in the ABCD3 gene: c.130C > T/p.Pro44Ser was detected in this patient. Through the analysis of pathogenicity prediction software, the mutations were disease-causing. This is the first report to identify the novel p.Pro44Ser mutations of ABCD3 gene in ICP patients.

Conclusions

Our report provides new insights into the genetic architecture of ICP involving ABCD3 variants. Early-onset severe refractory ICP is rare and mutations in bile acid metabolism genes might accentuate the phenotype. Emphasized perinatal management and screening for potential pathogenicity sites of variants that drive specific recognition of ICP is necessary.

Keywords

intrahepatic cholestasis of pregnancy - bile acids - ABCD3 - ursodeoxycholic acid - mutation

Publication History

Received: 19 September 2024

Accepted after revision: 31 October 2024

Article published online:
15 January 2025

• References

• 1 Girling J, Knight CL, Chappell L. Intrahepatic cholestasis of pregnancy: Green-top Guideline No. 43 June 2022. BJOG 2022; 129: e95-e114
• 2 Ovadia C, Seed PT, Sklavounos A. et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet 2019; 393: 899-909
• 3 Hague WM, Briley A, Callaway L. et al. Intrahepatic cholestasis of pregnancy – Diagnosis and management: A consensus statement of the Society of Obstetric Medicine of Australia and New Zealand (SOMANZ): Executive summary. Aust N Z J Obstet Gynaecol 2023; 63: 656-665
• 4 Dixon PH, Levine AP, Cebola I. et al. GWAS meta-analysis of intrahepatic cholestasis of pregnancy implicates multiple hepatic genes and regulatory elements. Nat Comm 2022; 13: 4840
• 5 Kullak-Ublick GA, Stieger B, Meier PJ. Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology 2004; 126: 322-342
• 6 Boyer JL. Bile formation and secretion. Compr Physiol 2013; 3: 1035-1078
• 7 Ferdinandusse S, Jimenez-Sanchez G, Koster J. et al. A novel bile acid biosynthesis defect due to a deficiency of peroxisomal ABCD3. Hum Mol Genet 2015; 24: 361-370
• 8 Kubitz R, Dröge C, Stindt J. et al. The bile salt export pump (BSEP) in health and disease. Clin Res Hepatol Gastroenterol 2012; 36: 536-553
• 9 Stapelbroek JM, van Erpecum KJ, Klomp LW. et al. Liver disease associated with canalicular transport defects: current and future therapies. J Hepatol 2010; 52: 258-271
• 10 Hague WM, Callaway L, Chambers J. et al. A multi-centre, open label, randomised, parallel-group, superiority Trial to compare the efficacy of URsodeoxycholic acid with RIFampicin in the management of women with severe early onset Intrahepatic Cholestasis of pregnancy: the TURRIFIC randomised trial. BMC Pregnancy Childbirth 2021; 21: 51
• 11 Corpechot C, Ping C, Wendum D. et al. Identification of a novel 974C-->G nonsense mutation of the MRP2/ABCC2 gene in a patient with Dubin-Johnson syndrome and analysis of the effects of rifampicin and ursodeoxycholic acid on serum bilirubin and bile acids. Am J Gastroenterol 2006; 101: 2427-2432
• 12 Ahmad TR, Haeusler RA. Bile acids in glucose metabolism and insulin signalling – mechanisms and research needs. Nat Rev Endocrinol 2019; 15: 701-712
• 13 Elfituri A, Ali A, Shehata H. Managing recurring obstetric cholestasis with metformin. Obstet Gynecol 2016; 128: 1320-1323
• 14 Monrose E, Bui A, Rosenbluth E. et al. Burden of future liver abnormalities in patients with intrahepatic cholestasis of pregnancy. Am J Gastroenterol 2021; 116: 568-575
• 15 Wikström Shemer EA, Stephansson O, Thuresson M. et al. Intrahepatic cholestasis of pregnancy and cancer, immune-mediated and cardiovascular diseases: A population-based cohort study. J Hepatol 2015; 63: 456-461